Analyst Estimates for Q2 2024Q1 2024Q2 2023Revenue$91.54 billion$88.44 billion$88.92 billionDiluted EPS$1.3488 cents$1.48Net Income$1.69 billion$1.12 billion$1.91 billion Key Metric: Net Income CVS lowered its projections for full-year earnings per share (EPS) in its last two earnings reports, citing higher-than-expected payouts for insurance claims as Americans undergo procedures covered by insurance at a greater rate than during the pandemic. The company said in each report that it was likely that medi ...